Litcius/Paper detail

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

Elise Fiala, Gowtham Jayakumaran, Audrey Mauguen, Jennifer A. Kennedy, Nancy Bouvier, Yelena Kemel, Megan Harlan Fleischut, Anna Maio, Erin Salo‐Mullen, Margaret Sheehan, Angela G. Arnold, Alicia Latham, Maria I. Carlo, Karen A. Cadoo, Semanti Murkherjee, Emily K. Slotkin, Tanya Trippett, Julia Glade Bender, Paul A. Meyers, Leonard H. Wexler, Filemon S. Dela Cruz, Nai‐Kong V. Cheung, Ellen M. Basu, Alex Kentsis, Michael V. Ortiz, Jasmine H. Francis, Ira J. Dunkel, Yasmin Khakoo, Stephen W. Gilheeney, Sameer Farouk Sait, Christopher J. Forlenza, Maria Luisa Sulis, Matthias A. Karajannis, Shakeel Modak, Justin T. Gerstle, Todd E. Heaton, Stephen S. Roberts, Ciyu Yang, Sowmya Jairam, Joseph Vijai, Sabine Topka, Danielle Novetsky Friedman, Zsofia K. Stadler, Mark E. Robson, Michael F. Berger, Nikolaus Schultz, Marc Ladanyi, Richard J. O’Reilly, David H. Abramson, Ozge Ceyhan‐Birsoy, Liying Zhang, Diana Mandelker, Neerav Shukla, Andrew L. Kung, Kenneth Offit, Ahmet Zehir, Michael F. Walsh

2021Nature Cancer171 citationsDOIOpen Access PDF

Topics & Concepts

PenetranceGermlineGermline mutationGenetic testingCancerMedicineOncologyInternal medicineFamily historyGeneticsBiologyMutationGenePhenotypeNeuroblastoma Research and TreatmentsCancer Genomics and DiagnosticsPancreatic and Hepatic Oncology Research